Affiliation:
1. Food and Drug Administration; Silver Spring Maryland USA
Funder
Office of Clinical Pharmacology
Office of New Drugs at the FDA
Subject
Pharmacology (medical),Pharmacology
Reference23 articles.
1. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N. Engl. J. Med.,2015
2. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma;Larkin;N. Engl. J. Med.,2015
3. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N. Engl. J. Med.,2015
4. Drug label for nivolumab BLA125554 2016 http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125554s022lbl.pdf
5. Wang , Y. Special considerations for modeling exposure-response relationships for biologics 2016
Cited by
155 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献